Universiteit Leiden

nl en

PhD defence

Exploring the role of Genetic Complexity in Pharmacogenomics

  • Q. Zhai
Date
Thursday 4 September 2025
Time
Location
Academy Building
Rapenburg 73
2311 GJ Leiden

Supervisor(s)

  • Prof.dr. T. van Gelder
  • Prof.dr. J.J. Swen
  • dr. M. van der Lee

Summary

Patients with the same disease can respond differently to the same medication due to factors like age, co-existing conditions, or co-medications. Personalized medicine aims to tailor treatments to individual characteristics to improve effectiveness and safety. Pharmacogenomics (PGx), a key component of personalized medicine, studies how a person’s genetic makeup affects their response to drugs. Its goal is to optimize drug therapy by maximizing benefits and minimizing side effects. In this thesis, on the one hand, we investigated how new technologies improve the detection and interpretation of genetic variations. On the other hand, we evaluated the effects of genetic variants on drug response, such as immunosuppressants and anti-cancer drugs, using cohorts and samples.

PhD dissertations

Approximately one week after the defence, PhD dissertations by Leiden PhD students are available digitally through the Leiden Repository, that offers free access to these PhD dissertations. Please note that in some cases a dissertation may be under embargo temporarily and access to its full-text version will only be granted later.

Press enquiries (journalists only)

pers@lumc.nl

General information

Beadle's Office
pedel@bb.leidenuniv.nl
+31 71 527 7211

This website uses cookies.  More information.